Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies
Authors:
- Jaydev R. UpponiJUJaydev R. Upponi
- Vladimir P. TorchilinVTVladimir P. Torchilin
- 1 May 2012
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 427 (1) , 3-20
Abstract
No abstract availableKeywords
This publication has 219 references indexed in Scilit:
- Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomesNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Dual-targeted polyplexes: One step towards a synthetic virus for cancer gene therapyJournal of Controlled Release, 2011
- Update on gene therapy for immunodeficienciesClinical Immunology, 2010
- RNAi‐based therapeutics–current status, challenges and prospectsEMBO Molecular Medicine, 2009
- Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomesJournal of Controlled Release, 2008
- Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenitaJournal of Dermatological Science, 2008
- Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?Drug Discovery Today, 2008
- Sheddable Coatings for Long-Circulating NanoparticlesPharmaceutical Research, 2007
- A phase I safety and dose escalation trial of docetaxel combined with GEM®231, a second generation antisense oligonucleotide targeting protein kinase A R1α in patients with advanced solid cancersInvestigational New Drugs, 2005
- Long-Term Expression with a Cationic Polymer Derived from a Natural Polysaccharide: SchizophyllanBioconjugate Chemistry, 2004